Organic Active Ingredients TRIZ Cases

Amniotic fluid stem cell spheroids administered via injection to treat urinary incontinence.

Dry powder remdesivir formulations with Captisol and leucine bypass intravenous infusion constraints to deliver therapeutic doses directly to the lungs.

A bifunctional luminogen merges an azole antibiotic with an aggregation-induced emission unit to generate reactive oxygen species.

Measuring IQGAP1 copy number gain predicts thyroid cancer invasiveness, resolving the trade-off between diagnostic complexity and prognosis accuracy.

Miricorilant reduces liver fat via selective glucocorticoid receptor modulation, addressing NAFLD progression and fibrosis risks.

Antisense oligomers target specific sequences to enable high-efficiency exon skipping in the human dystrophin gene.

Structural variations in phosphorus heterocycles yield stable phosphonimidate forms with tunable fluorescence for diagnostic assays.

Lrch4 modulation balances Toll-like receptor signaling to enhance immune response while preventing inflammatory tissue damage.

Immunohistochemical detection of the SPARC microenvironment signature predicts chemotherapy response, reducing toxicity from ineffective treatments.

Tafamidis fumaric acid co-crystals resolve stability and solubility trade-offs by dissolving at least 85 percent within fifteen minutes.

Optimized pH and concentration enable tapentadol aqueous formulations to achieve microbial control while eliminating preservative-related side effects.

Aryl-pyrazolyl motif compounds overcome bioavailability limits by selectively inducing apoptosis in neoplastic cells.

Isomyosmine inhibits monoamine oxidase enzymes to reduce cravings and dependence in patients with substance addiction.

Modifying the sugar ring at the 4' position creates compounds that maintain efficacy against mutant viral strains while reducing resistance risks.

Polymer conjugates modify lenalidomide to extend therapeutic plasma concentrations, reducing dosing frequency while minimizing gastrointestinal side effects.

Diol enhancers overcome poor stratum corneum permeation of hydrophilic avenanthramides, increasing therapeutic concentrations.

Structural modifications of diazepino-indole derivatives optimize pharmacokinetic profiles and eliminate CYP induction issues.

Crofelemer proanthocyanidin polymer composition reduces diarrhea frequency and improves stool consistency in patients.

A composite feed additive combines glucan, silica, and probiotics to promote aquatic animal growth.

Multi-armed polyoxazoline derivatives utilize mercaptide terminating agents to control molecular weight and ensure monofunctionality.

Native K3 proteins replace non-poxvirus markers to resolve time-consuming chemical selection bottlenecks in vaccine development.

Alkylated piperazine derivatives with dibenzofuran moieties increase receptor affinity, reducing L-DOPA induced dyskinesia in Parkinson's disease models.

Cyclodextrin-based complexes condense siRNA into nanoparticles, enabling endosomal escape and gene silencing without viral immunogenicity.

A topical skin healing formulation containing bioflavonoids and saponins treats varicose veins.

Novel low molecular weight compounds selectively inhibit the O-GlcNAcase enzyme to modulate protein glycosylation levels.

Deuterated imidazolidinedione compounds overcome drug resistance in prostate cancer treatment by enhancing metabolic stability.

Fusing vaccine antigens with exosome markers directs delivery via natural carriers, improving immunogenicity while eliminating genome integration risks.

Crystalline macitentan free base form I resolves storage instability in tropical climates by maintaining chemical purity without allergenic excipients.

Antisense oligonucleotides skip APP exon 17 to produce truncated APP646, preventing amyloid beta accumulation while preserving physiological roles.

Controlled deacetylation of chitosan restores glycocalyx integrity, reducing blood-brain barrier permeability.

Cell-penetrating peptide functionalized DNA origami nanostructures deliver siRNA while maintaining stability in serum and low magnesium environments.

Salt-stabilized diafiltration eliminates lyophilization, reducing process time and costs while maintaining stability.

A pharmaceutical composition combining cyanidins and delphinidins restores tight junction integrity in intestinal epithelial cells.

Oil-in-water emulsion dissolves mometasone furoate using butylene glycol to resolve solubility and cosmetic elegance trade-offs.

Phosphonate analogs prevent phosphatase inactivation while basic amino acid residues improve cell membrane penetration for high-affinity Plk1 binding.

Replacing methylene chloride with ethyl acetate eliminates hazardous solvent extraction steps, boosting yield and safety for this pyridine carboxamide.

Specific 2-phenylaminopyrimidine derivatives target LRRK2 to treat Parkinson's disease while avoiding off-target JAK2 kinase effects.

LOU064 modulates B cell function via cytokine shifts and partial inhibition to control MS disease activity while preserving protective immunoglobulin levels.

Zinc oxide particles in a cholecalciferol formulation block UVB light, resolving the trade-off between skin protection and vitamin D deficiency.

A pharmaceutical composition from Ocimum Sanctum promotes tumorigenic Schwann cell differentiation to treat malignant neurofibroma and melanoma.

Composite wound dressing layers combine citric acid and silver compounds to reduce biofilm formation by 2 log10 units within 12 hours.

Local vaginal delivery of S-ethylisothiouronium diethylphosphate reduces bleeding volume and cramp intensity without impacting breast or bone tissues.

Administering an IL-15 agonist alongside antibiotics counteracts immune suppression while maintaining antimicrobial efficacy.

An acrylic and silicone adhesive blend with soluble PVP increases estradiol flux, enabling smaller device sizes while maintaining daily dosages.

A nicotine delivery tablet combines direct compressible erythritol with distinct sugar alcohol particles to enhance salivation and taste.

Modified cellulose ether coatings isolate ibuprofen and codeine cores to prevent discoloration during storage.

Anifrolumab inhibits type I interferon signaling to resolve disease activity and reduce pain in systemic lupus patients.

Adding bivalent metal ions lowers glycosaminoglycan viscosity, enabling higher therapeutic concentrations via catheter without administration resistance.

S-N-(4-amino-6-methyl-5-quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide targets mutant EGFR receptors.

Intravenous baclofen solution prevents severe withdrawal symptoms by allowing rapid attainment of necessary drug concentrations and precise dose titration.

Mismatched guide strands enable 100-fold preferential silencing of mutant alleles while sparing wild-type gene function.

A pyrimidine sulfonamide compound with a specific chemical structure.

BDDE crosslinked hyaluronic acid gels retain anesthetic concentration after sterilization, preventing degradation of the filler matrix.

Fluorine-substituted fentanyl derivatives alter pKa to activate opioid receptors selectively in acidic inflamed tissues.

Hydroxypropyl chitosan forms an elastic film on the scalp to facilitate rapid penetration of active ingredients.

Segmented nanoparticles deliver dual ligands to activate natural killer cells at tumor sites, reducing off-target adverse events.

FL118 analogues target disease genes to deliver antitumor activity while reducing side-effect toxicities associated with topoisomerase I inhibition.

Antibodies targeting GPR49 reduce tumor volume and inhibit stem cells, addressing inadequate therapeutic options for cancer management.

Chocolate-derived fill material stabilizes probiotic supplements, preventing moisture-induced viability loss in softgel capsules.

Segmenting protein-rich plasma isolates N-Acetylneuraminic acid to inhibit interferon-alpha, resolving inconsistent autoimmune treatment outcomes.

Prostaglandin-ethanolamides exploit COX-2 metabolism to trigger endoplasmic reticulum stress and apoptosis in tumor cells while sparing healthy tissue.

Estra-1,3,5(10),16-tetraene derivatives inhibit AKR1C3 enzyme activity to reduce local estrogen concentrations in target tissues.

Seven compounds bind to the ATP binding site of cancer-specific PFK1 enzymes to inhibit glycolytic flux and reduce lactate generation.

Cell-penetrating peptides bypass P-glycoprotein efflux pumps to increase intracellular drug concentration and reduce systemic toxicity.

Fusion constructs link antibodies to LC3 proteins within exosomes to deliver cargo into target cells.

Selective pyrimidine compounds inhibit phosphodiesterase 10 to modulate striatal signaling, addressing severe side effects of current antipsychotic treatments.

Oral nutritional supplement replaces invasive injections with amino acid secretagogues that stimulate pituitary gland to release growth hormone.

PDGF antagonists inhibit signaling pathways to prevent mitral valve thickening and delay myxomatous valve disease onset.

Inhibiting the Paf1 complex enables small RNAs to trigger stable heterochromatin formation, overcoming inefficient gene silencing in animal cells.

Living radical polymerization produces low polydispersity zwitterionic conjugates, minimizing renal clearance and enhancing therapeutic stability.

Piperidino-pyrimidine derivatives modulate Toll-like receptors 7 and 8, improving metabolic stability while reducing cardiovascular risk.

Inhibiting Trim32 protein enhances glucose uptake in muscle cells, counteracting insulin resistance and atrophy.

A conditionally switchable nanostructure alters binding site accessibility through dynamic conformational changes triggered by coupling targets.

A natural composition of gallic acid, ellagic acid, and rubusoside inhibits angiogenesis through synergistic action.

Bolaamphiphilic vesicles encapsulate HIV active compounds to transport them across the blood-brain barrier, addressing CNS reservoir persistence.

Exosomes from hepatic cell-conditioned medium deliver specific microRNAs to inhibit hepatic stellate cell activation.

Magneto-electric nanoparticles release drugs via magnetic field induction, overcoming blood-brain barrier delivery limits.

A trans-scleral shunt with a biodegradable barrier layer enables repeated intraocular drug delivery while preventing infection and inflammation.

Salt forms and crystal structures of FGFR4 inhibitors provide enhanced stability while maintaining selectivity against FGFR1-3 kinases.

A lamb stomach extract and vitamin B12 preparation composition reverses gastric mucosal atrophy through synergistic enzymatic activity.

Angiogenin protein therapy delays disease progression and extends lifespan by addressing insufficient neurotrophic support in ALS patients.

Anti-CD39 antibodies block CD39 enzymatic activity to reduce extracellular adenosine levels, reversing immune suppression in the tumor microenvironment.

Dynamic polymer nanoparticle hydrogels provide controlled ocular drug release by synchronizing degradation with payload delivery to eliminate burst release.

Oral formulations with cannabinoids reduce chronic pain and inflammation in arthritic animals without surgical risks.

Allosteric pyrrolopyrimidine chaperones activate glucocerebrosidase via covalent binding, bypassing active site failures of existing pharmacological treatments.

Intranasal oxytocin acts as a positive allosteric modulator of the mu-opioid receptor to alleviate neonatal abstinence syndrome symptoms.

Composite spheroids with increased PD-L1 expression suppress inflammatory reactions to maintain pancreatic islet survival and insulin secretion.

Hydantoin compounds inhibit dUTPase to reverse resistance against thymidylate synthase inhibitors, restoring cancer treatment efficacy.

Opicapone extends levodopa plasma half-life by inhibiting COMT degradation, reducing absolute off-time and managing unpredictable motor fluctuations.